In an effort to boost innovation in the biotechnology sector, ZAGENO, a leading platform in AI-powered laboratory material procurement, has announced a strategic collaboration with Hatch.Bio Labs, a renowned incubator dedicated to nurturing startups in this field. The main objective of this alliance is to address the administrative challenges that these new companies often face, thus facilitating the progress of their research.
The partnership will allow residents of Hatch.Bio to streamline their laboratory supply procurement processes, enabling them to focus more on their research projects and less on logistical tasks. ZAGENO promises to provide a shopping experience comparable to e-commerce giants like Amazon, with features including discounted rates, easy price comparison among over 5,300 suppliers, and unified billing options.
Florian Wegener, CEO and founder of ZAGENO, emphasized the importance of this partnership, stating: “Biotech startups are at the forefront of innovation, but administrative hurdles can slow down their progress. Our collaboration with Hatch.Bio simplifies laboratory supply orders for their members, saving them valuable time and resources.”
In line with this, James Weis, CEO of Hatch.Bio, highlighted that this alliance gives residents of their incubator a significant operational advantage, facilitating agility in their operations and accelerating the development of crucial research.
The integration of ZAGENO’s platform with Hatch.Bio’s facilities and support aims to automate various processes and minimize the administrative tasks that researchers face. This will allow scientists to dedicate their time and effort to bringing their innovations to clinical practice. With a selection of over 40 million products from global suppliers, ZAGENO is establishing itself as an invaluable resource for laboratories of all sizes, improving efficiency and helping optimize budgets.
Both organizations are not only transforming laboratory supply procurement but also laying the groundwork for a future where biotechnological innovation can progress more rapidly, thanks to the reduction of operational barriers that have historically hindered progress in this sector.
Source: MiMub in Spanish
